Search

everythinglearnresearchcommunity

for

Search:↓

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Colostrum-derived exosomes can promote hair growth and may be a promising treatment for hair loss.

Environmental factors and grain products affect hair loss, with low cobalt in hair possibly predicting the condition.

Hormonal intrauterine devices (IUDs) may cause or worsen skin conditions influenced by androgens.

Androgenic alopecia in men is mainly linked to family history, hormonal imbalances, and metabolic issues, but can also be influenced by lifestyle habits, environmental factors, and deficiencies in certain vitamins and microelements like copper.

Finasteride does not negatively affect male reproductive function.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Platelet-rich plasma therapy shows promise in treating hair loss caused by androgenic alopecia.

The study created a test that found hormonal and toxic effects in plant and fungal extracts using prostate cancer cells.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Family history affects onset and severity of androgenic alopecia, but treatment success depends more on therapy duration.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

The study found that horizontal sections of scalp biopsies are better for analyzing hair loss, showing fewer hairs and more fine hairs in balding areas.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Smoking and drinking worsened hair loss in men with genetic hair loss, while eating and sleeping habits didn't; genetics played a bigger role than environment in hair loss.

PRP shows promise for treating hair loss but needs more research.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

Minoxidil helps stimulate hair growth and reduce hair loss in women with androgenic alopecia.

Women with PCOS and androgenic alopecia have different triglyceride metabolism compared to those without hair loss.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Hair loss may indicate a higher risk of heart disease and other health issues related to metabolism.

Platelet-rich plasma therapy can reduce hair loss and enhance hair growth in androgenetic alopecia patients, with no side effects observed.

Finasteride may not affect gynecomastia recurrence after mastectomy.

Sex hormones and antiandrogens can either stimulate or inhibit human hair follicle cell growth depending on the dose.